
Automate R&D and connect research to care with biological AI superintelligence.
Owkin AI is an AI biotech platform that uses agentic AI, like K Pro, to transform drug discovery, development, and diagnostics. It provides capabilities such as literature review, hypothesis testing, and data visualization, leveraging vast patient data networks. Best for pharmaceutical companies, biotech firms, and clinical researchers seeking to accelerate R&D and improve patient outcomes. Enterprise pricing; demo available.
Owkin is an AI biotech company that develops agentic AI platforms like K Pro to accelerate drug discovery, development, and diagnostics in healthcare. It processes complex patient data, identifies new drug candidates, and de-risks clinical trials. Owkin's AI is validated in real-world patients, continuously learning to refine predictions and accelerate decisions for pharmaceutical teams and researchers. Pricing is enterprise-focused.
K Pro, an AI agent driving insight generation and decision making across drug discovery and development, continuously learns from real-world data, user feedback, and clinical validation, evolving toward fully automated R&D.
Use Cases
Best For
Company Size
Complexity
Target Team Size
Target Skill Level
Base Models
Uses Models
Fair
Based on 6 verified signals
Email only (dpo@owkin.com)